Structure-activity relationships of GLP-1 analogs — anyone have experience?

NurseAsh_DET said:

Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Following on from NurseAsh_DET — and this may be the naive question:

What would you measure differently if you were starting again?

TrialTracker_MD said:

For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

I read this differently from TrialTracker_MD, on substance rather than tone. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

TrialTracker_MD said:

For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.